22nd Sep 2005 07:01
Vernalis PLC22 September 2005 22 September 2005 Vernalis Reports Appointment of Piper Jaffray as Joint Broker Vernalis plc (LSE: VER, NASDAQ: VNLS) today announces that it hasappointed Piper Jaffray Ltd as its joint broker, alongside JP Morgan Cazenove. - ends - Enquiries: Vernalis plc +44 (0) 118 977 3133Simon Sturge, Chief ExecutiveTony Weir, Chief Financial OfficerJulia Wilson, Head of Corporate Communications Brunswick Group +44 (0) 20 7404 5959Jon ColesWendel Verbeek About Vernalis Vernalis is a UK-based biotechnology company with a marketed migraine product,frovatriptan, and a development pipeline focused on central nervous systemdisorders and oncology. The company has five products in clinical developmentand collaborations with leading, global pharmaceutical companies includingNovartis, Biogen Idec and Serono. Vernalis is establishing a US commercialoperation to co-promote frovatriptan alongside its North American licensingpartner, Endo Pharmaceuticals, propelling the company towards its goal ofbecoming a sustainable, self-funding, R&D-driven biotechnology company. Forfurther information about Vernalis, please visit www.vernalis.com Safe Harbour statement: this news release may contain forward-looking statementsthat reflect the Company's current expectations regarding future events.Forward-looking statements involve risks and uncertainties. Actual events coulddiffer materially from those projected herein and depend on a number of factorsincluding the success of the Company's research strategies, the applicability ofthe discoveries made therein, the successful and timely completion of clinicalstudies, the uncertainties related to the regulatory process, the successfulintegration of completed mergers and acquisitions and achievement of expectedsynergies from such transactions, and the ability of the Company to identify andconsummate suitable strategic and business combination transactions. This information is provided by RNS The company news service from the London Stock ExchangeRelated Shares:
Vernalis PLC